Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)

Background Chemotherapy in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy is under debate. REACT study aimed to investigate the efficacy of reintroducing modified FOLFOX6 (mFOLFOX6) or CAPOX with or without bevacizumab in recurrent colorectal cancer patients af...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical oncology 2020-08, Vol.25 (8), p.1515-1522
Hauptverfasser:	Kotaka, Masahito, Iwamoto, Shigeyoshi, Satake, Hironaga, Sakai, Daisuke, Kudo, Toshihiro, Fukunaga, Mutsumi, Konishi, Ken, Ide, Yoshihito, Ikumoto, Taro, Tsuji, Akihito, Sano, Yasushi, Kato, Takeshi, Sugimoto, Naotoshi, Satoh, Taroh, Kanazawa, Akiyoshi, Kurata, Takayasu, Yamanaka, Takeharu, Tomita, Naohiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Bevacizumab Cancer Cancer Research Chemotherapy Colorectal cancer Colorectal carcinoma Confidence intervals Disease control Hypersensitivity Immunotherapy Medicine Medicine & Public Health Monoclonal antibodies Oncology Original Article Oxaliplatin Patients Peripheral neuropathy Reintroduction Surgical Oncology Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!